Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo

DNA topoisomerase II inhibitors e.g. doxorubicin and etoposide are currently used in the chemotherapy for acute lymphoblastic leukemia (ALL). These inhibitors have serious side effects during the chemotherapy e.g. cardiotoxicity and secondary malignancies. In this study we show that sulfonoquinovosy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Jain, Chetan Kumar, Pradhan, Bhola Shankar, Banerjee, Sukdeb, Mondal, Nirup Bikash, Majumder, Subeer S., Bhattacharyya, Madhumita, Chakrabarti, Saikat, Roychoudhury, Susanta, Majumder, Hemanta Kumar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4507174/
https://ncbi.nlm.nih.gov/pubmed/26189912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep12082
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak